BAILII is celebrating 24 years of free online access to the law! Would you consider making a contribution?
No donation is too small. If every visitor before 31 December gives just £1, it will have a significant impact on BAILII's ability to continue providing free access to the law.
Thank you very much for your support!
 |
[Home] [Databases] [World Law] [Multidatabase Search] [Help] [Feedback] | |
Statutory Rules of Northern Ireland |
||
|
You are here: BAILII >> Databases >> Statutory Rules of Northern Ireland >> The Misuse of Drugs (Designation) (Amendment) Regulations (Northern Ireland) 2021 No. 222 URL: http://www.bailii.org/nie/legis/num_reg/2021/nisr_2021222_en_1.html |
||
[New search] [Help]
This is the original version (as it was originally enacted). This item of legislation is currently only available in its original format.
Statutory Rules of Northern Ireland
Dangerous Drugs
Made
28th July 2021
Coming into operation
18th August 2021
The Department of Health( 1) makes the following Regulations in exercise of the powers conferred by section 7(4) and (5) of the Misuse of Drugs Act 1971 ( 2) as adapted by section 7(9) of that Act and now vested in it( 3) and after consultation with the Advisory Council on the Misuse of Drugs in accordance with section 7(7) of that Act.
1.—(1) This Order may be cited as the Misuse of Drugs (Designation) (Amendment) Order (Northern Ireland) 2021 and shall come into operation on 18th August 2021.
(2) The Interpretation Act (Northern Ireland) 1954( 4) shall apply to this Order as it applies to an Act of the Northern Ireland Assembly.
2.—(1) The following amendments are made to Part 1 of Schedule 1 to the Misuse of Drugs (Designation) Order (Northern Ireland) 2001( 5) (which specifies controlled drugs to which section 7(4) of the Misuse of Drugs Act 1971 applies).
(2) In paragraph 1(a)—
(a) after “Etryptamine” insert “Flualprazolam (8-chloro-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine)”;
(b) after “Flubromazolam (8-Bromo-6-(2-fluorophenyl)-1-methyl-4H -[1,2,4]triazolo[4,3-a][1,4] benzodiazepine)” insert “Flunitrazolam (6-(2-fluorophenyl)-1-methyl-8-nitro-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine)”;
(c) after “Nitrazolam (1-Methyl-8-nitro-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine)” insert “Norfludiazepam (7-chloro-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one)”.
Sealed with the Official Seal of the Department of Health on 28th July 2021
(L.S.)
Cathy Harrison
A senior officer of the Department of Health
(This note is not part of the Order)
This Order amends the Misuse of Drugs (Designation) Order (Northern Ireland) 2001 ( S.R. 2001 No. 431) (“the Order”).
Section 7(3) of the Misuse of Drugs Act 1971 (c. 38)(“the 1971 Act”) requires regulations to be made to allow the use for certain purposes, including medical use, of the drugs which are subject to control under that Act. Section 7(4)(b) of the 1971 Act provides, however, that designated controlled drugs will be exempt from this easement and so cannot lawfully be prescribed, administered, produced, compounded or supplied except under licence or other authority issued by the Department of Health. The designations in question are in the Misuse of Drugs (Designation) Order (Northern Ireland) 2001 (“the Order”). Part 1 of Schedule 1 to the Order is amended by adding flualprazolam, flunitrazolam and norfludiazepam to that Part (which specifies controlled drugs to which section 7(4) of the 1971 Act applies).
Formerly the Department of Health, Social Services and Public Safety; see 2016 c. 5 (N.I.), s. 1(5)
1971 c. 38as amended by section 151 of, and Schedule 17 to, the Police Reform and Social Responsibility Act 2011 c.13
S.R. & O. (N. I.) 1973 No. 504, Article 5(a) and S.I. 1999/283 (N.I. 1), Article 3(6)
S.R. 2001 No. 431, relevant amending Orders are S.R. 2019 No. 207, S.R. 2018 Nos. 174and 3, S.R. 2015 Nos. 228and 54, S.R. 2014 Nos. 262, 159and 20, S.R. 2013 No. 77, S.R. 2012 No. 212, S.R. 2011 No. 154, S.R. 2010 Nos. 246and 149, S.R. 2009 No. 389and S.R. 2005 No. 359
